Geopolitical Tensions & Second Wave Fears Send Stocks Lower
Fiona Cincotta June 17, 2020 4:31 PM
Geopolitical tensions in Asia, combined with fears of a second coronavirus flare up in China are weighing on risk sentiment, overshadowing hopes of a cheap covid-19 life saving drug.
Investors have turned cautious overnight as geopolitical tension in Asia, combined with fears of a second coronavirus flare up in China are weighing on risk sentiment, overshadowing hopes of a cheap covid-19 life saving drug. Asian markets moved lower, European bourses are pointing to a move southward on the open, meanwhile safe havens such as the US Dollar and gold are trading mildly higher.
News of a major breakthrough in the fight against coronavirus has failed to bring in a strong reaction in the market. A low dose, cheap steroid dexamethasone can hep save lives for those patients on ventilators. This is a positive step forward,which is helping to underpin sentiment.
In the UK, the FTSE looks set to fare marginally better than its European peers. Hopes that Boris Johnson could scarp the two-meter rule soon, in addition to optimism surrounding trade deals with Australia and New Zealand are helping to underpin sentiment.
GBP Gains As Inflation +0.5% yoy in May
The Pound has unexpectedly spiked into positive territory versus the USD following the release of some pretty grim inflation data. Consumer prices were flat month on moth in May, however, on an annual basis inflation increased a lacklustre 0.5%, down from 0.8% but in line with expectation. In a classic glass half full approach, the Pound is taking solace from the fact that inflation wasn’t worse than forecast.
This reading is unlikely to prompt the Bank of England to cut rates when it gives its rate announcement tomorrow. An additional £100 billion in QE is already priced in.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.